Literature DB >> 14999287

Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity.

Scott D McCulloch1, Robert J Kokoska, Chikahide Masutani, Shigenori Iwai, Fumio Hanaoka, Thomas A Kunkel.   

Abstract

Human DNA polymerase eta (Pol eta) modulates susceptibility to skin cancer by promoting DNA synthesis past sunlight-induced cyclobutane pyrimidine dimers that escape nucleotide excision repair (NER). Here we have determined the efficiency and fidelity of dimer bypass. We show that Pol eta copies thymine dimers and the flanking bases with higher processivity than it copies undamaged DNA, and then switches to less processive synthesis. This ability of Pol eta to sense the dimer location as synthesis proceeds may facilitate polymerase switching before and after lesion bypass. Pol eta bypasses a dimer with low fidelity and with higher error rates at the 3' thymine than at the 5' thymine. A similar bias is seen with Sulfolobus solfataricus DNA polymerase 4, which forms a Watson-Crick base pair at the 3' thymine of a dimer but a Hoogsteen base pair at the 5' thymine (ref. 3). Ultraviolet-induced mutagenesis is also higher at the 3' base of dipyrimidine sequences. Thus, in normal people and particularly in individuals with NER-defective xeroderma pigmentosum who accumulate dimers, errors made by Pol eta during dimer bypass could contribute to mutagenesis and skin cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999287     DOI: 10.1038/nature02352

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  116 in total

1.  Enzymatic switching for efficient and accurate translesion DNA replication.

Authors:  Scott D McCulloch; Robert J Kokoska; Olga Chilkova; Carrie M Welch; Erik Johansson; Peter M J Burgers; Thomas A Kunkel
Journal:  Nucleic Acids Res       Date:  2004-08-27       Impact factor: 16.971

2.  Rotational position of a 5-methylcytosine-containing cyclobutane pyrimidine dimer in a nucleosome greatly affects its deamination rate.

Authors:  Qian Song; Vincent J Cannistraro; John-Stephen Taylor
Journal:  J Biol Chem       Date:  2010-12-15       Impact factor: 5.157

3.  Backbone Flexibility Influences Nucleotide Incorporation by Human Translesion DNA Polymerase η opposite Intrastrand Cross-Linked DNA.

Authors:  Derek K O'Flaherty; F Peter Guengerich; Martin Egli; Christopher J Wilds
Journal:  Biochemistry       Date:  2015-12-16       Impact factor: 3.162

4.  Distinct mechanisms of cis-syn thymine dimer bypass by Dpo4 and DNA polymerase eta.

Authors:  Robert E Johnson; Louise Prakash; Satya Prakash
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

5.  Multiple solutions to inefficient lesion bypass by T7 DNA polymerase.

Authors:  Scott D McCulloch; Thomas A Kunkel
Journal:  DNA Repair (Amst)       Date:  2006-07-28

6.  Base pair opening in a deoxynucleotide duplex containing a cis-syn thymine cyclobutane dimer lesion.

Authors:  Belinda B Wenke; Leah N Huiting; Elisa B Frankel; Benjamin F Lane; Megan E Núñez
Journal:  Biochemistry       Date:  2013-12-11       Impact factor: 3.162

7.  Mutator alleles of yeast DNA polymerase zeta.

Authors:  Ayako N Sakamoto; Jana E Stone; Grace E Kissling; Scott D McCulloch; Youri I Pavlov; Thomas A Kunkel
Journal:  DNA Repair (Amst)       Date:  2007-08-21

8.  TRIP/NOPO E3 ubiquitin ligase promotes ubiquitylation of DNA polymerase η.

Authors:  Heather A Wallace; Julie A Merkle; Michael C Yu; Taloa G Berg; Ethan Lee; Giovanni Bosco; Laura A Lee
Journal:  Development       Date:  2014-02-19       Impact factor: 6.868

9.  Biochemical analysis of active site mutations of human polymerase η.

Authors:  Samuel C Suarez; Renee A Beardslee; Shannon M Toffton; Scott D McCulloch
Journal:  Mutat Res       Date:  2013-03-13       Impact factor: 2.433

10.  DNA damage tolerance: when it's OK to make mistakes.

Authors:  Debbie J Chang; Karlene A Cimprich
Journal:  Nat Chem Biol       Date:  2009-01-15       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.